Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research from O. Gluz and co-researchers provides new data on breast cancer
June 19th, 2008
According to recent research published in the journal Annals of Oncology, "This paper evaluates the prognostic and predictive impact of protein expression of various molecular markers in high- risk breast cancer ( HRBC) patients with > 9 involved lymph nodes, who received different chemotherapy dose- intensification strategies within a prospective randomized WSG AM- 01 trial. Paraffin- embedded tumors from 236 patients, who were randomly assigned to dose-dense conventional chemotherapy with four cycles of E90C600 followed by three cycles of C600M40F600 every 2 weeks ( DD) or a rapidly cycled tandem high- dose regimen with two cycles of E90C600 every 2 weeks followed by two cycles...
Source: Women's Health Weekly (2008-06-19)
|
|
Advertisement |
|
|
|
